Phototherapy device applied to metabolic diseases
A metabolic disease and phototherapy technology, applied in the field of phototherapy devices for metabolic diseases, to achieve the effects of variable shape, safety of temperature rise, and convenient wearing
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] Embodiment 1 Phototherapy device of the present invention
[0026] See figure 1 , figure 1 It is a structural schematic diagram of the phototherapy device of the present invention. The phototherapy device is provided with a flexible panel 1 , and the flexible panel 1 is ring-shaped without external force, and is provided with a wearing gap 2 . Semiconductor light emitting diodes 3 are arranged on the inner wall of the flexible panel 1, and the semiconductor light emitting diodes 3 are arranged in an array. A control unit integration device 4 is provided on the outer wall of the flexible panel 1 . Both ends of the flexible panel 1 are provided with matching fixing straps 5 .
[0027] See figure 2 , figure 2 It is a schematic diagram of the waveform of the PWM pulse driving method of the semiconductor light-emitting diode. Due to the limitation of LED heat dissipation technical conditions, the temperature rise of LEDs driven by constant current is serious, result...
Embodiment 2
[0031] Embodiment 2 Application of phototherapy device of the present invention to treat diabetes
[0032] 30 cases of diabetes were divided into three groups, 10 people in each group, and the phototherapy device of the present invention was used to give phototherapy. The light source for phototherapy in group A was ultraviolet LED with a peak wavelength of 340nm, the light source for group B was blue LED with a peak wavelength of 430nm, and the light source for group C was red LED with a peak wavelength of 635nm. Before receiving phototherapy, the average random blood glucose concentration of the patient was 17.5mmol / L, and the average fasting blood glucose concentration was 9.8mmol / L. After a 14-day period of 30 minutes of optical therapy per day, the random blood glucose concentration of patients in group A was 14.9mmol / L, and the fasting blood glucose concentration was 8.4mmol / L; the random blood glucose concentration of patients in group B was 12.8mmol / L , the fasting bl...
Embodiment 3
[0033] Embodiment 3 Application of phototherapy device of the present invention to treat hyperthyroidism
[0034] Divide 18 cases of hyperthyroidism into three groups, 6 people in each group, and give optical therapy. The light source for phototherapy in group A was ultraviolet LED with a peak wavelength of 340nm, the light source for group B was blue LED with a peak wavelength of 430nm, and the light source for group C was red LED with a peak wavelength of 635nm. Before receiving phototherapy, the average total T3 concentration of the patient was 3.75nmol / L, the average total T4 concentration was 185nmol / L, the average free T3 concentration was 13.53pmol / L, and the average free T4 concentration was 28pmol / L . After a 30-day period of 20 minutes of optical therapy per day, the average total T3 concentration of patients in group A was 3.13nmol / L, the average total T4 concentration was 166nmol / L, and the average free T3 concentration was 11.77pmol / L , the average free T4 concent...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com